Jan-Michel Heger

16PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematologyProsthetics and orthoticsCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 21, 2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Jan-Michel Heger, Julia Mattlener, Helen Kaul

|Sep 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma.

Jan-Michel Heger, Laman Mammadova, Julia Mattlener

|Aug 14, 2024
Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single-center retrospective analysis.

Marie Anne-Catherine Neumann, Jan-Hendrik Naendrup, Jorge Garcia Borrega

|Jun 27, 2024
Marked hyperferritinemia in critically ill cancer patients.

Paul Liedgens, Jan-Michel Heger, Noelle Sieg

|Feb 19, 2024
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.

Jan-Michel Heger, Yannick d'Hargues, Fanni Kleinert

Pageof 3

Frequent Collaborators

5 joint publications

Jessica Schneider

5 joint publications

Dennis A Eichenauer

5 joint publications

Michael J Hallek

5 joint publications

Bastian von Tresckow